The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influence of the new FIGO classification for cervical cancer on patients’ survival: Retrospective analysis of 265 histologically confirmed cases with FIGO stages Ia to IIb.
 
Nikolaus de Gregorio
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Amelie De Gregorio
Consulting or Advisory Role - AstraZeneca; Novartis; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - Daiichi Sankyo; Tesaro
 
Florian Ebner
No Relationships to Disclose
 
Fabienne Schochter
Honoraria - Pfizer
Expert Testimony - Roche Pharma AG
 
Thomas W. P. Friedl
Honoraria - Eisai; Novartis
Travel, Accommodations, Expenses - Roche
 
Jens Bodo Huober
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Celgene; Novartis; Pfizer; Roche
 
Wolfgang Janni
Honoraria - AstraZeneca; Janssen Diagnostics; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Menarini Silicon Biosystems; Novartis; Pfizer; Roche
Research Funding - Amgen (Inst); Janssen Diagnostics; Lilly (Inst); Menarini Silicon Biosystems; Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Peter Widschwendter
No Relationships to Disclose